Rowida Nasr - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Drug Development Research|May 27, 2026

Lead Discovery via Scaffold Refinement: Structure-Guided Optimization of 1,2,4-Triazolo[1,5-a]Pyrimidines as Potent Dual EGFR/CDK-2 Inhibitors Targeting Colorectal CarcinomaRowida Nasr, Hesham Haffez, Mohamed S Nafie, et al.

Archiv Der Pharmazie|July 17, 2026

Thiazole-Derived Dual EGFR/CDK-2 Inhibitors: Rational Design, Synthesis, In Vitro Anticancer Evaluation, Mechanistic Profiling, and Computational Binding AnalysisRowida Nasr, Mohamed S Nafie, Hesham Haffez, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Drug Development Research|May 27, 2026

Lead Discovery via Scaffold Refinement: Structure-Guided Optimization of 1,2,4-Triazolo[1,5-a]Pyrimidines as Potent Dual EGFR/CDK-2 Inhibitors Targeting Colorectal CarcinomaRowida Nasr, Hesham Haffez, Mohamed S Nafie, et al.

Archiv Der Pharmazie|July 17, 2026

Thiazole-Derived Dual EGFR/CDK-2 Inhibitors: Rational Design, Synthesis, In Vitro Anticancer Evaluation, Mechanistic Profiling, and Computational Binding AnalysisRowida Nasr, Mohamed S Nafie, Hesham Haffez, et al.

Pageof 1